Here is the latest financial fact sheet of PREVEST DENPRO. For more details, see the PREVEST DENPRO quarterly results and PREVEST DENPRO share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.8 |
No. of shares | m | 12.00 |
1 Week | % | 16.2 |
1 Month | % | 24.3 |
1 Year | % | 34.5 |
52 week H/L | Rs | 607.5/320.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PREVEST DENPRO EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 478 | 495 | |
Low | Rs | NA | NA | NA | 171 | 261 | |
Sales per share (Unadj.) | Rs | 6,425.7 | 7,589.7 | 981.9 | 31.8 | 41.5 | |
Earnings per share (Unadj.) | Rs | 998.0 | 1,669.7 | 248.5 | 9.6 | 13.1 | |
Diluted earnings per share | Rs | 2.5 | 4.2 | 6.0 | 9.6 | 13.1 | |
Cash flow per share (Unadj.) | Rs | 1,132.3 | 1,816.0 | 264.8 | 10.1 | 13.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 1.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0.3 | |
Book value per share (Unadj.) | Rs | 3,432.3 | 5,102.0 | 775.7 | 47.6 | 60.7 | |
Adj. book value per share | Rs | 8.6 | 12.8 | 18.7 | 47.6 | 60.6 | |
Shares outstanding (eoy) | m | 0.03 | 0.03 | 0.29 | 12.00 | 12.00 | |
Price / Sales ratio | x | 0 | 0 | 0 | 10.2 | 9.1 | |
Avg P/E ratio | x | 0 | 0 | 0 | 33.7 | 28.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 32.2 | 27.7 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 6.8 | 6.2 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 7.6 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 3,894 | 4,534 | |
Total wages/salary | Rs m | 35 | 45 | 34 | 41 | 55 |
PREVEST DENPRO INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 193 | 228 | 285 | 381 | 499 | |
Other income | Rs m | 5 | 18 | 10 | 16 | 20 | |
Total revenues | Rs m | 198 | 246 | 295 | 397 | 519 | |
Gross profit | Rs m | 39 | 52 | 90 | 152 | 198 | |
Depreciation | Rs m | 4 | 4 | 5 | 5 | 7 | |
Interest | Rs m | 2 | 3 | 3 | 3 | 2 | |
Profit before tax | Rs m | 38 | 63 | 93 | 161 | 210 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 8 | 13 | 21 | 45 | 52 | |
Profit after tax | Rs m | 30 | 50 | 72 | 116 | 157 | |
Gross profit margin | % | 20.1 | 22.8 | 31.7 | 39.9 | 39.7 | |
Effective tax rate | % | 20.3 | 20.2 | 22.8 | 27.9 | 25.0 | |
Net profit margin | % | 15.5 | 22.0 | 25.3 | 30.4 | 31.5 |
PREVEST DENPRO BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 100 | 156 | 236 | 527 | 543 | |
Current liabilities | Rs m | 33 | 38 | 65 | 54 | 54 | |
Net working cap to sales | % | 34.5 | 51.6 | 59.9 | 124.1 | 98.0 | |
Current ratio | x | 3.0 | 4.1 | 3.6 | 9.8 | 10.0 | |
Inventory Days | Days | 9 | 7 | 6 | 7 | 9 | |
Debtors Days | Days | 464 | 346 | 480 | 222 | 315 | |
Net fixed assets | Rs m | 54 | 55 | 71 | 114 | 243 | |
Share capital | Rs m | 3 | 3 | 3 | 120 | 120 | |
"Free" reserves | Rs m | 100 | 150 | 222 | 451 | 608 | |
Net worth | Rs m | 103 | 153 | 225 | 571 | 728 | |
Long term debt | Rs m | 14 | 16 | 14 | 14 | 0 | |
Total assets | Rs m | 153 | 211 | 307 | 641 | 786 | |
Interest coverage | x | 19.1 | 24.8 | 37.8 | 60.2 | 100.8 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.1 | 0 | 0 | |
Sales to assets ratio | x | 1.3 | 1.1 | 0.9 | 0.6 | 0.6 | |
Return on assets | % | 20.9 | 25.0 | 24.3 | 18.5 | 20.3 | |
Return on equity | % | 29.1 | 32.7 | 32.0 | 20.3 | 21.6 | |
Return on capital | % | 33.9 | 38.7 | 40.1 | 27.9 | 29.1 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 42.1 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 210 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 210 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 210 |
PREVEST DENPRO CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 30 | 47 | 88 | 70 | 107 | |
From Investments | Rs m | -12 | -5 | -19 | -39 | -124 | |
From Financial Activity | Rs m | 1 | 0 | -6 | 228 | -16 | |
Net Cashflow | Rs m | 19 | 42 | 63 | 259 | -33 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Atul Modi | COMP SEC: Aman Sadhotra | YEAR OF INC: 1999 | BSE CODE: 543363 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
More Medical Equipment/supplies/accessories Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare PREVEST DENPRO With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.